John F. Sheridan - Nov 28, 2022 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role: PRESIDENT & CEO, Director
Signature: /s/ Rachel Malina , Attorney-in-Fact for John F. Sheridan
Stock symbol: TNDM
Transactions as of: Nov 28, 2022
Transactions value $: -$16,093
Form type: 4
Date filed: 11/30/2022, 03:42 PM
Previous filing: Nov 17, 2022
Next filing: Feb 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNDM	Common Stock	Options Exercise	$0	+820	+6.04%	$0.00	14.4K	Nov 28, 2022	Direct
transaction	TNDM	Common Stock	Tax liability	-$16.1K	-407	-2.83%	$39.54	14K	Nov 28, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TNDM	Restricted Stock Unit	Options Exercise	$0	+820	+20.01%	$0.00	4.92K	Nov 28, 2022	Common Stock	820		Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2	Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").
F3	Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
F4	RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.